К содержанию
РецензированоEN2025

CORRECTION OF COGNITIVE IMPAIRMENTS IN CHRONIC CEREBRAL ISCHEMIA IN OUTPATIENT SETTINGS

САМИЕВ Аслиддин Сайитович · КИЛИЧЕВ Ибодулла Абдуллаевич · АДАМБАЕВ Зуфар Ибрагимович · ХУДОЙБЕРГАНОВ Нурмамат Юсупович · ПАЗЫЛОВА Аида Султановна

Статьи · 2025

Аннотация

To study the efficacy and safety of therapy with the herbal tea NeuroAid II in patients with chronic cerebral ischemia (CCI) in outpatient settings. Sixty-five patients aged 46-74 years (mean age 60.1±3.2 years) were examined. In all patients, the diagnosis of CCI was confirmed by clinical and neuroimaging methods. Patients of the 1st group (n=37) received basic therapy and the herbal medicinal collection NeuroAid II, the 2nd group (n=28) — only basic therapy. During therapy, patients of the 1st group showed statistically significant improvement in cognitive functions, a decrease in the severity of symptoms of depression and anxiety, and manifestations of asthenia. The treatment was characterized by good tolerability, the absence of adverse events and cases of drug interactions. Therapy with the herbal medicinal collection NeuroAid II in patients with chronic cerebral ischemia in outpatient settings provides relief of the main clinical manifestations of CCI, is characterized by good tolerability and safety.

Доказательный фрагмент

«To study the efficacy and safety of therapy with the herbal tea NeuroAid II in patients with chronic cerebral ischemia (CCI) in outpatient settings.»

Образец извлечения

Демо-превью

To study the efficacy and safety of therapy with the herbal tea NeuroAid II in patients with chronic cerebral ischemia (CCI) in outpatient settings. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники